Showing 1,656 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Pricey HCV Drugs Worth the Cost

Editor's pick
MedPage Today
27 November 2015
Hepatitis C transmission & prevention

The True Hepatitis C Prevalence in the United States: It's Higher Than What's Usually Reported

Editor's pick
Huffington Post
25 November 2015
Hepatitis C symptoms & diagnosis

Hepatitis C screening of prison inmates would benefit wider community, be cost-effective

Editor's pick
Eurekalert Inf Dis
24 November 2015
Hepatitis B

I am surviving only on 25 per cent of my liver today: Amitabh Bachchan

Editor's pick
The Indian Express
24 November 2015
Hepatitis C treatment

The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine Daclatasvir

Editor's pick
Medicines Patent Pool
23 November 2015
Finance & funding

Why We Should Be Willing to Pay for Hepatitis C Treatment

Editor's pick
Huffington Post
23 November 2015
Hepatitis C treatment

Leading liver doctors: Hepatitis C patients must be treated

Editor's pick
American Association for the Study of Liver Diseases press release
17 November 2015
Hepatitis C treatment

Pricing Pressures: How the Business of Medicine Affects the Price of Therapy

Editor's pick
Healio HCV Next
16 November 2015
Hepatitis C treatment

Medicare will spend $9 billion on Hepatitis-C drugs this year

Editor's pick
PBS NewsHour
16 November 2015
Hepatitis C transmission & prevention

UK: Almost half of people who inject drugs unaware they have hepatitis C

Editor's pick
Public Health England
13 November 2015
Hepatitis C treatment

U.S. FDA approves new indications for Harvoni®, Gilead’s once-daily single tablet regimen for chronic hepatitis C

Editor's pick
Gilled press release
13 November 2015
Access to healthcare

The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment

Editor's pick
Medicines Patent Pool
9 November 2015
Hepatitis C treatment

New hepatitis C drug can slow heart rate

Editor's pick
Health24
9 November 2015
Harm reduction

New Syringe Design Not Particularly Effective at Curbing Spread of Hepatitis C

Editor's pick
Yale News
6 November 2015
New & experimental hepatitis C treatment

Study suggests unprecedented 3-week hepatitis C cure

Editor's pick
Science
2 November 2015
Hepatitis C treatment

The Dark Side of Letting Insurance Payers Dictate Hepatitis C Treatment

Editor's pick
Huffington Post
2 November 2015
New & experimental hepatitis C treatment

Gilead Seeks FDA Approval for Hep C Treatment for All Genotypes

Editor's pick
AIDSMeds
2 November 2015
Hepatitis C treatment

Hepatitis C: behind new wonder drugs lies a terrible dilemma

Editor's pick
The Conversaion
29 October 2015
Hepatitis C treatment

Report: Hepatitis C in Eastern Europe and Central Asia: Civil society response to the epidemic

Editor's pick
International HIV/AIDS Alliance Ukraine
29 October 2015
Hepatitis C transmission & prevention

New research traces hepatitis C infections in Scotland back to WWII

Editor's pick
Medical Xpress
28 October 2015
Pharmaceutical industry

Gilead hepatitis C drug sales trend flattens, shares dip

Editor's pick
Reuters
28 October 2015
Hepatitis C treatment

New Yorkers on pace to spend $1 B. on Hepatitis C cures

Editor's pick
Capital New York
27 October 2015
Hepatitis C treatment

Hepatitis C Guidance Underscores the Importance of Treating HCV Infection: Panel Recommends Direct-Acting Drugs for Nearly All Patients with Chronic Hepatitis C

Editor's pick
IDSA
27 October 2015
Hepatitis C treatment

Prevalence and Care for Hep C Varies Widely Across Continent

Editor's pick
Medscape
27 October 2015